I

iBio
D

IBIO

0.80700
USD
-0.00
(-0.14%)
مغلق
حجم التداول
4,812
الربح لكل سهم
-2
العائد الربحي
-
P/E
-20
حجم السوق
13,331,060
أصول ذات صلة
A
ALT
-0.05500
(-0.95%)
5.71000 USD
A
AMRN
0.220
(2.00%)
11.220 USD
A
AXSM
0.810
(0.78%)
104.990 USD
E
EVOK
-0.03000
(-0.81%)
3.67000 USD
I
INO
-0.06000
(-2.98%)
1.95500 USD
T
TTNP
-0.17000
(-3.71%)
4.41000 USD
V
VSTM
0.83500
(11.16%)
8.31500 USD
X
XENE
-0.780
(-2.56%)
29.740 USD
المزيد
الأخبار المقالات

العنوان: iBio

القطاع: Healthcare
الصناعة: Biotechnology
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.